GDRX MEXC RealStocks
Own real GDRX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-13 22:58:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
GoodRx Holdings, Inc. (GDRX) operates in the SERVICES-COMPUTER PROCESSING & DATA PREPARATION sector and is listed on NASDAQ. The stock is currently priced at $3.56, with a market capitalization of $1.20B and a P/E ratio of 73.69. Over the past 52 weeks, its price has ranged from $1.77 to $3.89. This page covers its latest market performance, valuation, price trends and company information.
$1.20B | |
$3.56 | |
$3.61 | |
$3.48 | |
$3.51 | |
699.84K | |
1.15M | |
73.69 | |
$3.89 | |
$1.77 | |
-- | |
-- |
GoodRx Holdings, Inc. (GDRX) is trading at $3.54 in after-hours trading as of 2026-11-13 22:24:00, down 0.51% ($0.02) from the regular-session close of $3.56.
After-hours trading shows how investors are pricing GDRX after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, GoodRx Holdings, Inc. (GDRX) moved from $3.72 to $3.56, representing a decline of 4.44% ($0.17).
The stock traded between $3.33 and $3.80 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 1.18 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 84.2%
GDRX is currently trading at $3.56, placing it 84.2% of the way from its 52-week low of $1.77 to its 52-week high of $3.89. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
| Industry | SERVICES-COMPUTER PROCESSING & DATA PREPARATION |
| Employees | 697 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of GoodRx Holdings, Inc. (GDRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to GDRX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between GDRX shares and USD.
GDRX Shares to USD
1.00 GDRX shares = 3.555 USD
Calculations are estimates based on the latest available price and are for reference only.